Business
Fitch affirms Pakistan’s ‘B-’ ratings with stable outlook, signals improved credit stability | The Express Tribune
Updates sovereign rating criteria from Sept 2025, incorporating recovery assumptions into debt ratings for first time
Global ratings agency Fitch on Wednesday affirmed Pakistan’s long-term foreign- and local-currency debt ratings at ‘B-’ with a stable outlook and assigned a ‘RR4’ recovery rating to the country’s senior unsecured instruments.
The rating action follows Fitch’s adoption of revised Sovereign Rating Criteria, effective from September 2025, under which recovery assumptions have been formally incorporated into sovereign debt ratings for the first time. The agency also removed the ratings from Under Criteria Observation (UCO).
Although ‘B-‘ indicates that Pakistan remains a high-risk borrower with significant credit vulnerabilities, the recent affirmation reflects a relative improvement. The rating was upgraded from ‘CCC+’ in April 2025 due to improved fiscal management, IMF-supported reforms, and stabilised external buffers.
This signals to lenders modest confidence and greater stability in Pakistan’s credit profile, potentially easing access to financing at somewhat lower (though still elevated) costs. It also encourages continued support from creditors, provided reforms continue.
According to Fitch, Pakistan’s senior unsecured long-term debt, including global bonds and sukuk issued under The Pakistan Global Sukuk Programme Company Limited, has been equalised with the sovereign’s Long-Term Foreign-Currency Issuer Default Rating (IDR).
The agency said the equalisation reflects expectations of average recovery prospects in a default scenario. This is given Pakistan’s elevated government debt levels, high interest payments as a share of revenue, and the absence of structural or legal features that would warrant notching the debt ratings above or below the sovereign IDR.
Topline Research, citing Fitch, noted that securities assigned an ‘RR4’ recovery rating are historically associated with recoveries in the range of 31% to 50% of current principal and related interest. This provides investors with additional guidance on downside risk in a stress or default scenario. The removal of UCO indicates that Fitch has completed its criteria review and does not reflect a change in Pakistan’s underlying credit fundamentals.
The upgrade on April 15, 2025, from ‘CCC+’ to ‘B-’ reflected improved macroeconomic stability, progress under the IMF-supported programme, tighter fiscal and monetary policies, and enhanced external financing assurances. Fitch reiterated that the latest rating action primarily reflects a methodological update rather than a reassessment of Pakistan’s credit profile.
Governance challenges remain a key constraint on Pakistan’s sovereign rating. Fitch assigned Pakistan an ESG Relevance Score of ‘5’ for political stability, rule of law, institutional strength, regulatory quality, and control of corruption, in line with its assessment framework for sovereigns.
These scores are driven by the high weighting of the World Bank Governance Indicators (WBGI) in Fitch’s Sovereign Rating Model. Pakistan’s WBGI ranking stands at the 22nd percentile, highlighting persistent weaknesses in policy predictability, institutional effectiveness, and governance outcomes.
Also Read: Pakistan moving forward with ‘sense of achievement and progress’, PM Shehbaz says on WEF’s sidelines
Data compiled by Topline Research shows that Pakistan’s sovereign rating trajectory has been volatile over the past decade, reflecting recurring balance-of-payments pressures and fiscal stress.
After maintaining a ‘B’ rating in 2015, Pakistan was downgraded multiple times, reaching ‘CCC-’ in February 2023 during the peak of external liquidity stress. Subsequent improvements in financing conditions and IMF support led to gradual stabilisation, culminating in the upgrade to ‘B-’ in April 2025, which has now been reaffirmed.
Fitch warned that Pakistan’s ratings remain sensitive to developments in public and external finances. On the downside, failure to place government debt and debt-servicing metrics on a clear downward path could lead to negative rating action. The agency also highlighted risks stemming from renewed deterioration in external liquidity, including potential delays in IMF programme reviews, weaker policy implementation, or insufficient external financing inflows.
On the upside, Fitch said a positive rating action could be triggered by material and sustained reductions in public debt and interest burdens. This is particularly the case if fiscal consolidation is implemented in line with IMF commitments and leads to structural improvements in tax revenue mobilisation.
Further easing of external financing risks, including improved access to international capital and a durable build-up of foreign exchange reserves beyond Fitch’s current projections, would also support an upgrade.
Business
Stock markets outlook: Dalal Street braces for swings as RBI MPC decision, war risks weigh on sentiment–Check key triggers – The Times of India
Domestic equities are expected to remain volatile this week as investors track the Reserve Bank’s monetary policy decision, global macroeconomic cues and evolving developments in the West Asia conflict, analysts said, according to PTI.Market participants will also keep a close watch on crude oil price movements and foreign fund flows, which continue to influence sentiment.Vinod Nair, Head of Research at Geojit Investments Ltd, said the RBI’s Monetary Policy Committee (MPC) meeting will be the key domestic trigger, with investors focusing on the central bank’s stance on inflation and growth.“A rate pause is near-certain consensus, the central bank walks a tightrope between crude-driven inflation risks and a four-year low Manufacturing PMI signalling a softening growth impulse. The governor’s commentary on the rate cycle trajectory and FY27 projections will be closely monitored.“Globally, the US March CPI reading will carry significant importance, as it buries residual Fed rate-cut hopes, strengthens the dollar and tightens financial conditions for emerging markets, including India,” Nair said.He added that geopolitical developments in West Asia will remain the dominant factor shaping market direction.“Indian markets return after a three-day gap and remain acutely vulnerable to weekend war developments, with crude trajectory and any credible ceasefire signal being the decisive variable that could either trigger a sharp relief rally or extend the current sell-on-rise mode,” he said.In the previous holiday-shortened week, the BSE Sensex declined 263.67 points, or 0.35%, while the NSE Nifty fell 106.5 points, or 0.46%.Siddhartha Khemka, Head of Research (Wealth Management) at Motilal Oswal Financial Services Ltd, said investor sentiment will remain closely linked to developments in the West Asia conflict.Brent crude prices have stayed elevated near $107 per barrel, fuelling concerns around imported inflation. Currency pressures have also intensified, with the rupee weakening sharply before recovering towards Rs 93 against the US dollar following RBI intervention, he noted.Foreign institutional investor (FII) outflows remain a key overhang, with March witnessing heavy selling of Rs 1.2 lakh crore, among the highest monthly outflows in recent years.“Investors will monitor the US Federal Open Market Committee (FOMC) meeting minutes, GDP data, and initial jobless claims for further cues on growth and the policy trajectory.“Overall, markets are expected to remain volatile as geopolitical developments, crude price movements, FII flows and global macro data continue to drive sentiment,” Khemka said.Analysts said any signs of de-escalation in the West Asia conflict could ease crude prices and stabilise the currency, offering relief to markets, while further escalation may prolong risk aversion and keep pressure on foreign flows.
Business
Home heating oil costs in rural Lancashire doubles – councillors
One elderly couple had to find £1,000 for an oil delivery and suppliers are not giving quotes, a councillor says.
Source link
Business
Middle East conflict may hit India’s exports beyond region if prolonged, says government – The Times of India
A prolonged conflict in Middle East could begin to hurt India’s exports not just to the region but also to other global markets, as disrupted supply chains ripple outward, commerce secretary Rajesh Agrawal said on Saturday, He also urged the pharmaceutical industry to reduce dependence on imported raw materials and build more resilient export and import linkages.Speaking on the sidelines of ‘Chintan Shivir – Scaling Up Pharma Exports’ in Hyderabad, Agrawal said the government has already seen an impact on both imports and exports over the past month because of the Middle East crisis, with energy imports and regional trade flows under pressure.
“Middle East is also an important market. Around 12-13 per cent of our exports go to the region. So, that will directly get impacted. And if it goes on for long, maybe our exports to other parts of the world will also get impacted as some of the value chains will rotate back. We are cognizant of it,” Agrawal told reporters, as per news agency PTI.He said the exact impact of the conflict on India’s trade would become clearer in the next couple of weeks, but indicated that both exports and imports could see some decline.“And I assume, it will not only be a one-way traffic, in terms of export going down, but it will also be imports having some downfall,” he said.Agrawal cautioned that even if the war ends soon, the disruption may linger for months or even years, depending on the extent of damage to supply chains and infrastructure.“So, at this juncture, it will be very difficult to take a very long-term view on it,” he said.He said the Centre is trying to ensure that supply chains face the minimum possible disruption, while acknowledging that some trade numbers may soften in the near term.
Pharma sector already feeling supply pressure
The commerce secretary said the pharmaceutical sector has already seen some impact in the availability of key intermediates and solvents because supply chains are getting affected by the regional crisis.Agrawal said all arms of the government are working to prioritise limited LPG supply and are attempting to ease the situation by diversifying imports and sourcing from alternative suppliers.“So, as we are able to resolve that overall supply, we will try to alleviate some of the pain in every sector. The Pharma sector will be one of the priority sectors,” he said.He added that the government and industry are jointly working on ways to make supply chains more resilient.
Call for self-reliance in APIs, bulk drugs and intermediates
At the same event, Agrawal asked the pharmaceutical industry to use the current geopolitical uncertainty as a trigger to reduce dependence on critical imported inputs and strengthen domestic capacity.Addressing industry stakeholders in Hyderabad, he stressed “the importance of ensuring greater self-reliance by meeting 80-90 per cent (or higher) of domestic pharmaceutical requirements through indigenous production, while reducing critical import dependencies in APIs, bulk drugs, and intermediates”.He also emphasised the “importance of insulating import supply chains in a geopolitically fragmented world, where availability may be important”.Agrawal called for a broader strategic repositioning of India as a global hub for quality, affordable pharmaceuticals, saying that quality would remain the decisive factor in healthcare. He urged the sector to build a stronger quality ecosystem to enhance global trust and align with emerging areas such as biologics and biosimilars.He also encouraged the industry to shift from a volume-driven to a value-driven model, with greater focus on innovation and new patents, while maintaining India’s strength in generics.
Exports remain on positive path despite uncertainty
Despite the geopolitical overhang, Agrawal said India’s exports in the last financial year were expected to remain on a positive trajectory.The broader pharmaceutical export picture remains resilient. India’s pharma exports stood at $30.47 billion in 2024-25, up 9.4 per cent over the previous year.During April–February 2025-26, pharma exports reached $28.29 billion, registering growth of over 5 per cent compared with the corresponding period of the previous year.India remains the third-largest producer of pharmaceuticals globally by volume and 14th by value, underscoring both the sector’s scale and the stakes involved in insulating it from external shocks.
-
Sports1 week agoUSMNT handed reality check by Doku, Belgium ahead of World Cup
-
Sports1 week ago2026 NCAA men’s hockey tournament: Schedule, results
-
Fashion1 week agoEU apparel imports slump 15.48% YoY in Jan; Bangladesh hardest hit
-
Uncategorized6 days ago
[CinePlex360] Please moderate: “Further tariff
-
Uncategorized1 week ago
[CinePlex360] Please moderate: “Apple scrapping
-
Entertainment1 week agoThe Avett Brothers’ bassist explains why he wrote a book about John Quincy Adams
-
Sports1 week agoMan City show why they are worthy WSL title winners as tired United wilt
-
Entertainment1 week agoDemystifying the PTI
